JP Morgan Chase’s MedEquities Realty Trust, Inc. MRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-162,460
Closed -$1.81M 6174
2019
Q1
$1.81M Buy
162,460
+150,451
+1,253% +$1.63M ﹤0.01% 3404
2018
Q4
$82K Buy
12,009
+2,180
+22% +$17.1K ﹤0.01% 4921
2018
Q3
$95K Buy
9,829
+3,017
+44% +$32K ﹤0.01% 4977
2018
Q2
$75K Sell
6,812
-13,086
-66% -$135K ﹤0.01% 4942
2018
Q1
$210K Buy
19,898
+13,717
+222% +$146K ﹤0.01% 4353
2017
Q4
$69K Sell
6,181
-3,684
-37% -$41.7K ﹤0.01% 4791
2017
Q3
$118K Buy
+9,865
New +$117K ﹤0.01% 4260
2017
Q2
Sell
-13,985
Closed -$157K 5390
2017
Q1
$157K Sell
13,985
-15,880
-53% -$177K ﹤0.01% 4177
2016
Q4
$332K Buy
+29,865
New +$334K ﹤0.01% 3946

JP Morgan Chase's MRT Position: Q2 2019 in Review

JP Morgan Chase sold out of MedEquities Realty Trust, Inc. (MRT) in Q2 2019, closing a stake of 162,460 shares — an estimated $1.81M sold.

JP Morgan Chase first reported a position in MRT in Q4 2016 and held it in 9 quarters. The position peaked at $1.81M in Q1 2019. 0 funds tracked by Wall St. Rank hold MRT as of Q2 2019.

  • JP Morgan Chase reported no remaining MedEquities Realty Trust, Inc. position as of Q2 2019 after selling out during the quarter.
  • JP Morgan Chase sold 162,460 MedEquities Realty Trust, Inc. shares in Q2 2019, an estimated $1.81M.
  • JP Morgan Chase first reported a position in MedEquities Realty Trust, Inc. in Q4 2016 and held it in 9 quarters.
  • JP Morgan Chase's MedEquities Realty Trust, Inc. position peaked at $1.81M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q2 2019.

Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.